MZTI Stock Analysis: The Marzetti | NASDAQ
Packaged Foods | NASDAQ, USA | Market Cap: 3.075m USD | 12M Return: -33.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 36.9M
EPS Trend: 86.3%
Qual. Beats: -1
Rev. Trend: 95.6%
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Marzetti Company (NASDAQ: MZTI) is a U.S.-based specialty food manufacturer that operates through two segments: Retail and Foodservice. The company sells its products through sales personnel, food brokers, and distributors to retailers and restaurants, relying on a multi-channel go-to-market approach common within the consumer staples sector.
MZTIs brand portfolio spans frozen baked goods (New York Bakery, Sister Schuberts), salad dressings and dips (Marzetti, Cardinis, Girards), croutons and toppings (Chatham Village), and frozen pasta. In addition to owned brands, the company generates revenue through brand licensing agreements with major restaurant chains, including Olive Garden, Buffalo Wild Wings, Chick-fil-A, Texas Roadhouse, and Subway-a co-manufacturing and licensing model that is widely used in the packaged food industry to extend distribution without assuming direct retail marketing costs.
The company was founded in 1896 and is headquartered in Westerville, Ohio. It was previously known as Lancaster Colony Corporation before adopting the Marzetti Company name in June 2025, reflecting the growing prominence of the Marzetti brand within its portfolio.
- Olive Garden and Chick-fil-A licensing fuels foodservice segment growth
- Commodity input costs pressure gross margins across retail and foodservice
- Retail frozen bread and dressing volumes drive category growth
| Net Income: 175.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 3.26 > 1.0 |
| NWC/Revenue: 16.24% < 20% (prev 13.43%; Δ 2.81% < -1%) |
| CFO/TA 0.23 > 3% & CFO 316.8m > Net Income 175.8m |
| Net Debt (-181.2m) to EBITDA (298.4m): -0.61 < 3 |
| Current Ratio: 2.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.4m) vs 12m ago -0.43% < -2% |
| Gross Margin: 24.19% > 18% (prev 23.70%; Δ 0.49% > 0.5%) |
| Asset Turnover: 147.4% > 50% (prev 147.8%; Δ -0.38% > 0%) |
| Interest Coverage Ratio: 65.41 > 6 (EBIT TTM 229.5m / Interest Expense TTM 3.51m) |
| A: 0.23 (Total Current Assets 513.9m - Total Current Liabilities 198.9m) / Total Assets 1.36b |
| B: 1.25 (Retained Earnings 1.69b / Total Assets 1.36b) |
| C: 0.17 (EBIT TTM 229.5m / Avg Total Assets 1.32b) |
| D: 3.36 (Book Value of Equity 1.04b / Total Liabilities 311.3m) |
| Altman-Z'' = 10.28 = AAA |
| DSRI: 0.89 (Receivables 98.3m/106.9m, Revenue 1.94b/1.89b) |
| GMI: 0.98 (GM 23.70% / 24.19%) |
| AQI: 0.96 (AQ_t 0.18 / AQ_t-1 0.19) |
| SGI: 1.03 (Revenue 1.94b / 1.89b) |
| TATA: -0.10 (NI 175.8m - CFO 316.8m) / TA 1.36b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of July 13, 2026, the stock is trading at USD 114.80 with a total of 181,249 shares traded. Over the past week, the price has changed by -0.85%, over one month by +2.86%, over three months by -19.15% and over the past year by -33.25%.
Current recommended Stop Loss: 108.10 (which is 5.8% or 1.9 ATR below the current price).
The Marzetti has no consensus analysts rating.
P/E Trailing = 17.8016
P/E Forward = 36.1011
P/S = 1.5851
P/B = 2.947
P/EG = 3.1204
Revenue TTM = 1.94b USD
EBIT TTM = 229.5m USD
EBITDA TTM = 298.4m USD
Long Term Debt = unknown (none)
Short Term Debt = 11.7m USD (from shortTermDebt, last fiscal year)
Debt = 37.2m USD (from shortLongTermDebtTotal, last quarter) (leases 37.2m already included)
Net Debt = -181.2m USD (calculated: Debt 37.2m - CCE 218.4m)
Enterprise Value = 2.89b USD (3.08b + Debt 37.2m - CCE 218.4m)
Interest Coverage Ratio = 65.41 (Ebit TTM 229.5m / Interest Expense TTM 3.51m)
EV/FCF = 11.67x (Enterprise Value 2.89b / FCF TTM 248.0m)
FCF Yield = 8.57% (FCF TTM 248.0m / Enterprise Value 2.89b)
FCF Margin = 12.78% (FCF TTM 248.0m / Revenue TTM 1.94b)
Net Margin = 9.06% (Net Income TTM 175.8m / Revenue TTM 1.94b)
Gross Margin = 24.19% ((Revenue TTM 1.94b - Cost of Revenue TTM 1.47b) / Revenue TTM)
Gross Margin QoQ = 23.65% (prev 26.50%)
Tobins Q-Ratio = 2.13 (Enterprise Value 2.89b / Total Assets 1.36b)
Interest Expense / Debt = 9.43% (Interest Expense 3.51m / Debt 37.2m)
Taxrate = 22.18% (50.1m / 226.0m)
NOPAT = 178.6m (EBIT 229.5m * (1 - 22.18%))
Current Ratio = 2.58 (Total Current Assets 513.9m / Total Current Liabilities 198.9m)
Debt / Equity = 0.04 (Debt 37.2m / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = -0.61 (Net Debt -181.2m / EBITDA 298.4m)
Debt / FCF = -0.73 (Net Debt -181.2m / FCF TTM 248.0m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.36% (Net Income 175.8m / Total Assets 1.36b)
RoE = 17.35% (Net Income TTM 175.8m / Total Stockholder Equity 1.01b)
RoCE = 19.83% (EBIT 229.5m / Capital Employed (Total Assets 1.36b - Current Liab 198.9m))
RoIC = 16.66% (NOPAT 178.6m / Invested Capital 1.07b)
WACC = 6.32% (E(3.08b)/V(3.11b) * Re(6.31%) + D(37.2m)/V(3.11b) * Rd(9.43%) * (1-Tc(0.22)))
Discount Rate = 6.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -6.67 | Cagr: -0.10%
[DCF] Terminal Value 77.97% ; FCFF base≈225.5m ; Y1≈258.5m ; Y5≈380.5m
[DCF] Fair Price = 215.4 (EV 5.73b - Net Debt -181.2m = Equity 5.91b / Shares 27.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 86.25 | EPS CAGR: 8.16% | SUE: -3.79 | # QB: -1
Revenue Correlation: 95.64 | Revenue CAGR: 2.09% | SUE: N/A | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.78 | Chg30d=-1.66% | Revisions=-40% | Analysts=3
EPS current Year (2026-06-30): EPS=6.77 | Chg30d=-3.45% | Revisions=-57% | GrowthEPS=+0.7% | GrowthRev=+0.9%
EPS next Year (2027-06-30): EPS=7.22 | Chg30d=-1.96% | Revisions=-57% | GrowthEPS=+6.6% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -77% (up=0, down=10)